Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease

Babiloni C, Infarinato F, Aujard F, Bastlund JF, Bentivoglio M, Bertini G, Del Percio C, Fabene PF, Forloni G, Herrero Ezquerro MT, Noè FM, Pifferi F, Ros-Bernal F, Christensen DZ, Dix S, Richardson JC, Lamberty Y, Drinkenburg W, Rossini PM.

Clin Neurophysiol. 2013 Mar;124(3):437-51. doi: 10.1016/j.clinph.2012.07.023. Epub 2012 Oct 4.

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain

Sultana R, Perluigi M, Butterfield DA.

Free Radic Biol Med. 2013 Sep;62:157-169. doi: 10.1016/j.freeradbiomed.2012.09.027. Epub 2012 Oct 5.

Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects

Martínez-Sánchez F, Meilán JJ, García-Sevilla J, Carro J, Arana JM.

Neurologia. 2013 Jul-Aug;28(6):325-31. doi: 10.1016/j.nrl.2012.07.012. Epub 2012 Oct 6.

Non-coding RNAs in Alzheimer's disease

Tan L, Yu JT, Hu N, Tan L.

Mol Neurobiol. 2013 Feb;47(1):382-93. doi: 10.1007/s12035-012-8359-5. Epub 2012 Oct 7.

Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison

Franciotti R, Falasca NW, Bonanni L, Anzellotti F, Maruotti V, Comani S, Thomas A, Tartaro A, Taylor JP, Onofrj M.

Neurobiol Aging. 2013 Apr;34(4):1148-58. doi: 10.1016/j.neurobiolaging.2012.09.015. Epub 2012 Oct 11.

CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease

Li L, Yin Z, Liu J, Li G, Wang Y, Yan J, Zhou H.

J Neurol. 2013 Jul;260(7):1701-8. doi: 10.1007/s00415-012-6690-4. Epub 2012 Oct 16.

Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study

Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M.

J Neural Transm (Vienna). 2013 May;120(5):813-9. doi: 10.1007/s00702-012-0902-z. Epub 2012 Oct 18.

Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis

Yuan H, Xia Q, Ge P, Wu S.

Mol Biol Rep. 2013 Feb;40(2):1827-34. doi: 10.1007/s11033-012-2237-0. Epub 2012 Oct 19.

Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease

Pluta R, Furmaga-Jabłońska W, Maciejewski R, Ułamek-Kozioł M, Jabłoński M.

Mol Neurobiol. 2013 Feb;47(1):425-34. doi: 10.1007/s12035-012-8360-z. Epub 2012 Oct 19.

The capillary dysfunction hypothesis of Alzheimer's disease

Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Møller A, Brændgaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ.

Neurobiol Aging. 2013 Apr;34(4):1018-31. doi: 10.1016/j.neurobiolaging.2012.09.011. Epub 2012 Oct 18.

Astrocyte signaling and neurodegeneration: new insights into CNS disorders

Brambilla L, Martorana F, Rossi D.

Prion. 2013 Jan-Feb;7(1):28-36. doi: 10.4161/pri.22512. Epub 2012 Oct 23.

Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients

Babiloni C, Del Percio C, Bordet R, Bourriez JL, Bentivoglio M, Payoux P, Derambure P, Dix S, Infarinato F, Lizio R, Triggiani AI, Richardson JC, Rossini PM.

Clin Neurophysiol. 2013 May;124(5):837-50. doi: 10.1016/j.clinph.2012.09.017. Epub 2012 Oct 23.

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology

Harada R, Okamura N, Furumoto S, Tago T, Maruyama M, Higuchi M, Yoshikawa T, Arai H, Iwata R, Kudo Y, Yanai K.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):125-32. doi: 10.1007/s00259-012-2261-2. Epub 2012 Oct 26.

Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease

Gauthier S, Molinuevo JL.

Alzheimers Dement. 2013 May;9(3):326-31. doi: 10.1016/j.jalz.2011.11.005. Epub 2012 Oct 27.

Feasibility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer's disease: a pilot randomized controlled trial

Suttanon P, Hill KD, Said CM, Williams SB, Byrne KN, LoGiudice D, Lautenschlager NT, Dodd KJ.

Clin Rehabil. 2013 May;27(5):427-38. doi: 10.1177/0269215512460877. Epub 2012 Nov 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias